Corporate

  • May 05, 2025

    Officials Seek More Depo Time In Live Nation Antitrust Suit

    U.S. officials have asked a Manhattan federal court to extend deposition time in a lawsuit accusing Live Nation of anticompetitive practices in ticket sales to live entertainment events, saying they need more hours to seek testimony from several entities and individuals who were recently disclosed in the case.

  • May 05, 2025

    House GOP Eyes Expanded CFTC Oversight Of Crypto

    House Republicans indicated Monday that they want the U.S. Commodity Futures Trading Commission to play a key role in overseeing digital asset markets, a draft proposal that followed weekend pushback from Democratic senators opposed to other crypto legislation targeting so-called stablecoins.

  • May 05, 2025

    How Law Firms Have Handled The EEOC's Push For DEI Data

    Perkins Coie LLP dug in its heels and scored a court order quashing the U.S. Equal Employment Opportunity Commission's inquiry into its diversity, equity and inclusion programs, while seven other firms the EEOC targeted opted to negotiate. Here’s what Law360 knows about what law firms have done in response to the commission’s March request for workplace diversity information.

  • May 05, 2025

    USPTO's AI Head Latest To Leave Agency

    The U.S. Patent and Trademark Office's leader for all matters related to artificial intelligence will be departing the agency, according to a source familiar with personnel moves at the agency.

  • May 05, 2025

    Burger King Can't Chop Claims It Cooked Up Misleading Ads

    Burger King can't toss a proposed class action alleging its advertisements misrepresent the size and amount of toppings in its iconic Whopper hamburger, a Florida federal judge ruled Monday, saying the consumers have plausibly alleged the advertisement photos "go beyond mere exaggeration or puffery."

  • May 05, 2025

    Levi Strauss Beats Former Exec's Sex-Bias Suit At Trial

    A California federal jury Monday cleared Levi Strauss of sex-bias claims brought by a former company executive who claims she was skipped over for a senior director's role after announcing her pregnancy, reaching their decision in about 20 minutes after a one-week trial.

  • May 05, 2025

    Google Ads Advertisers Ask For Class Cert. In MDL

    A group of advertisers in multidistrict litigation accusing Google of violating antitrust law through its control over key ad technology has asked a New York federal court to certify it as a class.

  • May 05, 2025

    Celsius Exec Decries 'Venom-Laced' Gov't Sentencing Memo

    The founder of defunct cryptocurrency platform Celsius told a Manhattan federal judge that a sentencing memorandum in which prosecutors asked for a 20-year prison sentence was a "venom-laced" attempt to paint him as a "fiend" and ignore his prior law-abiding business ventures and status as a Soviet Jewish refugee.

  • May 05, 2025

    Ex-Twitter Execs Can See Some Musk Texts In Severance Row

    Four former Twitter executives claiming they are owed $200 million in severance will be able to conduct a search of Elon Musk's text messages, but only when it comes to iMessage and not other messaging platforms like Signal, a California federal judge ruled.

  • May 05, 2025

    Trump Seeks 100% Tariff On Foreign-Made Movies

    President Donald Trump asked his administration to place a 100% tariff on foreign-made movies, with a spokesperson telling Law360 on Monday that a final decision on the plan hadn't been made.

  • May 05, 2025

    Rite Aid Hits Bankruptcy Less Than A Year After Previous Ch. 11

    Drugstore chain Rite Aid Corp. reentered bankruptcy Monday less than a year after its earlier reorganization plan was approved, filing for Chapter 11 protection in New Jersey bankruptcy court with more than $1 billion in debt and plans for an asset sale.

  • May 05, 2025

    Calif. Chamber Gets Acrylamide Cancer Warnings Deleted

    A California federal judge has sided with the state's Chamber of Commerce in a suit challenging Proposition 65's requirement that companies warn buyers about dietary acrylamide in their products, finding that it violates the First Amendment's protections against compelled speech.

  • May 05, 2025

    Clifford Chance Adds Paul Weiss Exec Compensation Atty In NY

    Clifford Chance LLP has added a Paul Weiss Rifkind Wharton & Garrison LLP transactional attorney in New York as co-chair of its U.S. executive compensation practice, the firm announced Monday.

  • May 05, 2025

    Skechers Inks $9.4B Take-Private Deal Guided By 3 Firms

    Private equity firm 3G Capital will take footwear giant Skechers private for $9.4 billion in a deal guided by three law firms amid an ongoing trade war that has rattled retailers, the parties announced Monday.

  • May 05, 2025

    5 Firms Pilot Pershing Square's $900M Howard Hughes Deal

    Hedge fund Pershing Square will grow its ownership stake in Howard Hughes Holdings and expand the company's business lines beyond real estate development in a $900 million deal put together by five law firms, the companies said Monday.

  • May 05, 2025

    Kaiser Permanente Escapes 401(k) Forfeiture Suit, For Now

    A California federal judge tossed a proposed class action alleging Kaiser Permanente misspent forfeitures from an employee 401(k) plan, concluding the allegations failed to state a claim for a violation of federal benefits law.

  • May 05, 2025

    Real Estate Ace Rejoins V&E In Dallas After In-House Roles

    Vinson & Elkins LLP announced Monday that it has strengthened its real estate practice with a partner in Dallas who returns to the firm after nearly a decade of in-house work.

  • May 05, 2025

    American Airlines Sues Chicago Over O'Hare Gate Space

    American Airlines said in a lawsuit filed Friday in Illinois federal court that the city of Chicago breached its contract with the airline in reassigning gate space at O'Hare International Airport in a way that favors competitor United Airlines.

  • May 05, 2025

    Umpqua Bank Class Seeks Approval Of $55M Ponzi Suit Deal

    A class of Umpqua Bank investors has asked a California federal judge to give the initial OK to a $55 million settlement to end a suit alleging the bank helped execute a $300 million Ponzi scheme led by a since-deceased real estate investment manager.

  • May 05, 2025

    Novartis, Incyte Settle Drug Royalty Fight On Eve Of Trial

    A Manhattan federal judge put off trial on Monday in a five-year quest by Novartis to recover what it says are $500 million in missing royalties from its agreement to commercialize an Incyte compound used to treat blood cancers, with the sides announcing they reached a settlement.

  • May 05, 2025

    Coal Miner Says It Must Liquidate Without Creditor Deal

    Counsel for the owners of Heritage Coal told a Delaware bankruptcy judge on Monday that if secured and unsecured creditors cannot reach a deal by Tuesday, the company will have to move to convert its bankruptcy from a Chapter 11 to a Chapter 7 liquidation.

  • May 05, 2025

    Akin Hires Ex-Trump Trade Official From Hogan Lovells

    Akin Gump Strauss Hauer & Feld LLP said Monday it has hired the former co-leader of Hogan Lovells' geopolitical risk and national security program, who is bringing perspective from that role and experience navigating international economic issues at the White House to Akin's lobbying and public policy team.

  • May 02, 2025

    Ex-Abercrombie CEO Isn't Fit To Stand Trial, Judge Agrees

    A New York federal judge Friday held that former Abercrombie & Fitch Co. CEO Michael Jeffries is indeed incapable of understanding the sex trafficking litigation against him and must be hospitalized for a few months to determine "whether his competency may be restored."

  • May 02, 2025

    Judge Axes Trump's Perkins Order With Shakespearean Flourish

    A Washington, D.C., federal judge on Friday struck down as unconstitutional President Donald Trump's retaliatory executive order targeting Perkins Coie LLP, permanently blocking enforcement of the directive and likening the president's action to a Shakespeare character's suggestion that the way to amass power is to "kill all the lawyers."

  • May 02, 2025

    Abbott Beats Bellwether In Formula MDL Ahead Of Trial

    An Illinois federal judge Friday held that Abbott Laboratories isn't liable for the death of a baby who consumed its Similac baby formula, entering judgment in favor of Abbott in a bellwether case in multidistrict litigation that was set to head to trial in a little over a week.

Expert Analysis

  • What Compensation Committees Must Keep In Mind In 2025

    Author Photo

    New disclosure obligations, an evolving discussion on the analysis of executive perks and updated proxy adviser policies — on top of a new presidential administration — are all important things compensation committees must pay close attention to in 2025, say attorneys at Simpson Thacher.

  • The Future Of ALJs At NLRB And DOL Post-Jarkesy

    Author Photo

    In the wake of the U.S. Supreme Court’s 2024 Jarkesy ruling, several ongoing challenges to the constitutionality of the U.S. Department of Labor's and the National Labor Relations Board's administrative law judges have the potential to significantly shape the future of administrative tribunals, say attorneys at Wiley Rein.

  • Engaging With Feds On Threats To Executives, Employees

    Author Photo

    In an increasingly polarized environment, where companies face serious concerns about how to protect executives and employees, counsel should consider working with federal law enforcement soon after the discovery of threats or harassment, says Jordan Estes at Gibson Dunn.

  • Losing A Motion To Dismiss Ruling Isn't Necessarily The End

    Author Photo

    A recent Delaware Court of Chancery ruling, that the Manti Group had not demonstrated any conflicts of interest favoring private equity fund operator The Carlyle Group, serves as an important reminder that a decision on a pleading motion is not the end of the story, say attorneys at Sidley.

  • Drug Cartels' Terrorist Label Raises Litigation Risk For Cos.

    Author Photo

    President Donald Trump's planned designation of some Latin American drug-trafficking groups as foreign terrorist organizations creates an additional and little-noticed source of legal exposure: U.S. civil litigation risk involving terrorism claims by victims of those groups, say attorneys at Covington.

  • How Cos. Can Prepare Now For SEC E-Filing System Changes

    Author Photo

    The U.S. Securities and Exchange Commission's amendments to the Electronic Data Gathering, Analysis and Retrieval system are designed to improve access to and management of EDGAR accounts, and with the March 24 effective date fast approaching, and the transition requiring significant coordination, companies should begin planning now, say attorneys at Debevoise.

  • The Tides Are Changing For Fair Access Banking Laws

    Author Photo

    The landscape of fair access banking laws, which seek to prevent banks from denying services based on individuals' ideological beliefs, has shifted in the last few years, but a new presidential administration provides renewed momentum for advancing such legislation against the backdrop of state efforts, say attorneys at Latham.

  • Imagine The Possibilities Of Openly Autistic Lawyering

    Author Photo

    Andi Mazingo at Lumen Law, who was diagnosed with autism about midway through her career, discusses how the legal profession can create inclusive workplaces that empower openly autistic lawyers and enhance innovation, and how neurodivergent attorneys can navigate the challenges and opportunities that come with disclosing one’s diagnosis.

  • A Halftime Analysis Of DOJ's Compensation Pilot Program

    Author Photo

    The U.S. Department of Justice appears to consider the first half of its three-year pilot program on compensation incentives and clawbacks to be proceeding successfully, so companies should expect prosecutors to emphasize the program and other compliance-related considerations early in investigations, say attorneys at Debevoise.

  • 4 Keys To Litigating In An Active Regulatory Environment

    Author Photo

    For companies facing litigation influenced by government regulatory action — a recent trend that a politically charged atmosphere will exacerbate — there are a few principles that can help to align litigation strategy with broader public positioning in the regulatory and oversight context, say attorneys at Jenner & Block.

  • Kiromic SEC Order Shows Importance Of Self-Reporting

    Author Photo

    The U.S. Securities and Exchange Commission's recently filed settled charges against Kiromic BioPharma illustrate the critical intersection between U.S. Food and Drug Administration regulatory processes and investor disclosures under the securities laws, and showcase how responding promptly to internal whistleblower reports may reap benefits, say attorneys at Arnold & Porter.

  • Series

    Documentary Filmmaking Makes Me A Better Lawyer

    Author Photo

    Becoming a documentary filmmaker has allowed me to merge my legal expertise with my passion for storytelling, and has helped me to hone negotiation, critical thinking and problem-solving skills that are important to both endeavors, says Robert Darwell at Sheppard Mullin.

  • Litigation Funding Disclosure Debate: Strategy Considerations

    Author Photo

    In the ongoing debate over whether courts should require disclosure of litigation funding, funders and plaintiffs tend to argue against such mandates, but voluntarily disclosing limited details about a funding arrangement can actually confer certain benefits to plaintiffs in some scenarios, say Andrew Stulce and Marc Cavan at Longford Capital.

  • Justices Likely To Stay In ERISA's Bounds On Pleadings

    Author Photo

    The arguments in Cunningham v. Cornell showed the U.S. Supreme Court's willingness to resolve a circuit split regarding Employee Retirement Income Security Act pleading standards by staying within ERISA's confines, while instructing courts regarding what must be pled to survive a motion to dismiss, says Ryan Curtis at Fennemore Craig.

  • Scope And Nature Of Judicial Relief Will Affect Loper's Impact

    Author Photo

    The practical result of post-Loper Bright rulings against regulatory actions will depend on the relief courts grant — and there has been controversy in these types of cases over whether the ruling is applied just to the parties or nationwide, and whether the action can be left in place while it's corrected, says Steven Gordon at Holland & Knight.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Corporate archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!